Post-hepatectomy liver failure has a major impact on patient outcome. This study aims to explore the impact of the integration of a novel patient-centred evaluation, the LiMAx algorithm, on perioperative patient outcome after hepatectomy. Trends in perioperative variables and morbidity and mortality rates in 1170 consecutive patients undergoing elective hepatectomy between January 2006 and December 2011 were analysed retrospectively. Propensity score matching was used to compare the effects on morbidity and mortality of the integration of the LiMAx algorithm into clinical practice. Over the study period, the proportion of complex hepatectomies increased from 29.1% in 2006 to 37.7% in 2011 (P = 0.034). Similarly, the proportion of patients with liver cirrhosis selected for hepatic surgery rose from 6.9% in 2006 to 11.3% in 2011 (P = 0.039). Despite these increases, rates of post-hepatectomy liver failure fell from 24.7% in 2006 to 9.0% in 2011 (P < 0.001) and liver failure-related postoperative mortality decreased from 4.0% in 2006 to 0.9% in 2011 (P = 0.014). Propensity score matching was associated with reduced rates of post-hepatectomy liver failure [24.7% (n = 77) versus 11.2% (n = 35); P < 0.001] and related mortality [3.8% (n = 12) versus 1.0% (n = 3); P = 0.035]. Postoperative liver failure and postoperative liver failure-related mortality decreased in patients undergoing hepatectomy following the implementation of the LiMAx algorithm.
Although aorto‐hepatic conduits (AHC) provide an effective technique for arterialization in liver transplantation (LT), when the native recipient artery is unusable, various publications report higher occlusion rates and impaired outcome compared to conventional anastomoses. This systematic review and meta‐analysis investigates the published evidence of outcome and risk of AHC in LT using bibliographic databases and following the PRISMA guidelines. Primary and secondary outcome were artery occlusion as well as graft and patient survival. Twenty‐three retrospective studies were identified with a total of 22,113 LT, of whom 1,900 patients (9%) received an AHC. An AHC was used in 33% of retransplantations. Early artery occlusion occurred in 7% (3‐16%) of patients with AHC, compared to 2% (1‐3%) without conduit (OR 3.70; 1.63‐8.38; p=0.001). The retransplantation rate after occlusion was not significantly different in both groups (OR 1.46; 0.67‐3.18; p=0.35). Graft (HR 1.38; 1.17‐1.63; p<0.001) and patient (HR 1.57; 1.12‐2.20; p=0.009) survival was significantly lower in the AHC compared to the non‐conduit group. In contrast, graft survival in retransplantations was comparable (HR 1.00; 0.82‐1.22; p=0.986). Although AHC provide an important rescue option, when regular revascularization is not feasible during LT, transplant surgeons should be alert of the potential risk of inferior outcome.